Open AccessEffect of lamivudine in HBeAg-positive chronic hepatitis B: Discordant effect on HBeAg and HBV DNA according to pretreatment ALT level
Author(s) -
Tomoko Kurihara,
Fumio Imazeki,
Osamu Yokosuka,
Kenichi Fukai,
Tatsuo Kanda,
Sadaaki Kawai,
Hiromitsu Saisho
Publication year - 2005
Publication title -
world journal of gastroenterology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.427
H-Index - 155
eISSN - 2219-2840
pISSN - 1007-9327
DOI - 10.3748/wjg.v11.i22.3346
Subject(s) - hbeag , gastroenterology , lamivudine , medicine , chronic hepatitis , hepatitis b , group a , hepatitis b virus , immunology , virus , hbsag
To clarify differences in antiviral effect of the drug in patients with different ALT levels, we examined the changes in HBV markers in patients with high or low ALT levels with or without lamivudine treatment.